[pubmed] Association of HLA Class II Alleles with Disease Severity and Treatment Response in Iranian Patients with Myast
Posté : 31 mai 2021 12:00
J Neuromuscul Dis. 2021 May 26. doi: 10.3233/JND-210700. Online ahead of print.
ABSTRACT
Myasthenia gravis is an autoimmune neuromuscular disease with a multifactorial etiology. A major part of the genetic susceptibility belongs to the HLA encoding genes. In this study, we investigated the role of HLA class II polymorphism in disease severity, and treatment response. In our 146 patients, 15 DRB1, 7 DQA1, and 9 DQB1 alleles, and 19 haplotypes were found. Adjusted p-values did not show any significant associations between these loci, disease severity and treatment outcome. Further studies in different populations with a larger number of patients are needed to determine the exact contribution of HLA class II alleles to MG prognosis.
PMID:34057095 | DOI:10.3233/JND-210700
Source: https://pubmed.ncbi.nlm.nih.gov/3405709 ... 5&v=2.14.4